Clovis Oncology
CLVS
#10899
Rank
โ‚น1.12 B
Marketcap
โ‚น7.79
Share price
0.00%
Change (1 day)
-94.64%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -โ‚น16.87 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are โ‚น0.13 Billion. In 2021 the company made an earning of -โ‚น22.37 Billion, an increase over its 2020 earnings that were of -โ‚น33.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น16.87 Billion-24.59%
2021 -โ‚น22.37 Billion-32.64%
2020 -โ‚น33.21 Billion-9.06%
2019 -โ‚น36.51 Billion7.49%
2018 -โ‚น33.97 Billion4.42%
2017 -โ‚น32.53 Billion-8.83%
2016 -โ‚น35.68 Billion-0.4%
2015 -โ‚น35.82 Billion140.82%
2014 -โ‚น14.88 Billion86.64%
2013 -โ‚น7.97 Billion19.53%
2012 -โ‚น6.67 Billion
2010 -โ‚น2.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.490 T-12,049.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.015 T-4,971.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น572.88 B-2,848.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.984 T-14,416.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.405 T-6,845.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
โ‚น36.97 B-277.36%๐Ÿ‡บ๐Ÿ‡ธ USA